menu search

Krystal biotech announces first patient dosed in phase 1 clinical trial of kb407 for the treatment of cystic fibrosis

PITTSBURGH, July 03, 2023 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a biotechnology company focused on developing...

July 3, 2023, 11:00 am

Bitcoin rises as crypto traders brush off blackrock etf fears

Cryptos dropped last Friday following a report that the SEC called high-profile applications for Bitcoin ETFs inadequate. Traders now don’t seem pha...

July 3, 2023, 9:59 am

: astrazeneca shares slump after phase 3 lung cancer drug study

AstraZeneca’s AZNUK:AZN shares slumped 6% in premarket trade. The U.K. drugmaker said its datopotamab deruxtecan treatment showed positive results i...

July 3, 2023, 9:36 am

Astrazeneca plummets, sacrificing a breakout, on mixed results in lung cancer treatment

AstraZeneca and Daiichi Sankyo reported mixed results Monday from a final-phase study of their lung can...

July 3, 2023, 9:17 am

Nls pharmaceutics shares rise as narcolepsy treatment moves to phase 3 studies

Shares of NLS Pharmaceutics Ltd. NLSP, +19.57% gained 12% premarket on Monday after the Swiss clinical-stage biopharma company said it would proceed w...

July 3, 2023, 8:53 am

Mannkind shares fall after fire that may delay clinical trial

Shares of MannKind Corp. MNKD, +2.78% fell 1.5% premarket on Monday after the biopharma company said a fire at a German manufacturing facility may del...

July 3, 2023, 8:27 am

Labcorp spins off fortrea contract research organization with stock debut on the nasdaq

Labcorp LH, +0.35% said Monday it completed the spin-off of Fortrea FTREV, -3.98% as an independent contract research organization (CRO) that speciali...

July 3, 2023, 8:23 am

Astrazeneca shares slump after phase 3 lung cancer drug study

AstraZeneca's AZN, +1.02% AZN, -5.43% shares slumped 6% in premarket trade. The U.K. drugmaker said its datopotamab deruxtecan treatment showed positi...

July 3, 2023, 5:36 am

Allovir: several late-stage programs make this worth a look

Positive final results from the phase 2 study, using posoleucel for BK Virus, were presented at the Ame...

July 1, 2023, 3:48 am

: biden’s student loan ‘on-ramp’ explained: missed payments won’t hurt credit, but interest keeps adding up

Here’s what you need to know about the next phase of the Biden administration’s student loan forgiv...

June 30, 2023, 10:00 pm

Does this technical analysis pattern make amazon a buy?

Amazon recently moved into a bullish phase, according to a technical analysis pattern. But it's important to remember technical analysis has no predic...

June 30, 2023, 3:42 pm

Memecoin mooky raises $900,000 ahead of its final presale stage

­­Memecoin Mooky is gearing up for its final presale phase, having raised $900,000 to date. More than just a novel crypto token, Mooky aims to suppo...

June 30, 2023, 11:39 am

Genfit shares fall despite positive trial results for rare cholestatic liver disease therapeutic

GENFIT (NASDAQ:GNFT) shares fell 5% after initially rising on positive results from its clinical trial with partner Ipsen for the investigational the...

June 30, 2023, 10:46 am

Why is enphase energy (enph) stock up today?

Enphase Energy (NASDAQ: ENPH ) stock is on the rise Friday as investors react to the company expanding ...

June 30, 2023, 10:45 am

Enphase (enph) extends distribution partnership with 4blue

Enphase (ENPH) extends distribution partnership with 4blue to capitalize on the growing demand for sola...

June 30, 2023, 9:57 am

Enphase energy's stock jumps after analyst says investors should start buying

Shares of Enphase Energy Inc. jumped Friday, after B. Riley analyst Christopher Souther provided a bull...

June 30, 2023, 9:49 am

Navidea biopharmaceuticals rejects prophase labs offer

Navidea Biopharmaceuticals Inc. NAVB, -2.38% announced Friday that it had rejected an unsolicited Prophase ...

June 30, 2023, 9:44 am

Technical analysis & forecast for june 30, 2023

Gold is in a consolidation phase before a potential decline. This overview also covers the latest devel...

June 30, 2023, 8:37 am

Chitogenx reports first quarter results, highlights milestone in rotator cuff repair phase i/ii trial

ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) has noted that patient recruitment for its rotator cuff repair phase ...

June 30, 2023, 8:13 am

France june preliminary cpi +4.5% vs +4.6% y/y expected

Prior +5.1%HICP +5.3% vs +5.4% y/y expectedPrior +6.0%That's a positive development on the face of it but a lot of that still has to do with higher en...

June 30, 2023, 6:45 am


Search within

Pages Search Results: